Tumor-derived IL-6 may contribute to the immunological defect in CLL
Open Access
- 1 November 2007
- journal article
- letter
- Published by Springer Science and Business Media LLC in Leukemia
- Vol. 22 (5), 1084-1087
- https://doi.org/10.1038/sj.leu.2405015
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Chronic lymphocytic leukemia cells induce changes in gene expression of CD4 and CD8 T cellsJCI Insight, 2005
- Antiapoptotic Microenvironment of Acute Myeloid LeukemiaThe Journal of Immunology, 2004
- The two faces of IL-6 on Th1/Th2 differentiationMolecular Immunology, 2002
- Serum Levels of IL-6 Type Cytokines and Soluble IL-6 Receptors in Active B-Cell Chronic Lymphocytic Leukemia and in Cladribine Induced RemissionMediators of Inflammation, 1999
- The cellular biology of B-cell chronic lymphocytic leukemia.Critical Reviews in Oncology/Hematology, 1998
- Acquired CD40-ligand deficiency in chronic lymphocytic leukemiaNature Medicine, 1997
- Interleukin-6 Inhibits Apoptosis and Tumour Necrosis Factor Induced Proliferation of B-Chronic Lymphocytic LeukaemiaLeukemia & Lymphoma, 1996
- The biology of interleukin-6Blood, 1989